Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 24 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 8952185

    Production method of optically active dihydrobenzofuran derivative

    Takeda Pharmaceutical Company Limited · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  2. US 8940758

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted
  3. US 8937055

    Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action

    Takeda Pharmaceutical Company Limited · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted
  4. US 8933105

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  5. US 8933069

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  6. US 8932853

    Method for manufacturing pancreatic-hormone-producing cells

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  7. US 8927718

    Fused heterocyclic ring derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted
  8. US 8927016

    Producing a sustained-release preparation

    Takeda Pharmaceutical Company Limited · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted
  9. US 8926969

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted
  10. US 8921354

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  11. US 8921379

    Fused ring compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  12. US 8921326

    Sustained-release composition and method for producing the same

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  13. US 8920840

    Enteric tablet

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  14. US 8921358

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  15. US 8916549

    Thienooxazepine derivative

    Takeda Pharmaceutical Company Limited · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted
  16. US 8916566

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted
  17. US 8916551

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted
  18. US 8906901

    Administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  19. US 8907089

    Fused heterocyclic ring derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  20. US 8901309

    Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

    Takeda Pharmaceutical Company Limited · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  21. US 8900638

    Solid preparation comprising alogliptin and metformin hydrochloride

    Takeda Pharmaceutical Company Limited · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  22. US 8901141

    Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them

    Takeda Pharmaceutical Company Limited · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  23. US 8901171

    Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

    Takeda Pharmaceutical Company Limited · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  24. US 8895591

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted